Executive vice president, government and public relations · ZEVRA THERAPEUTICS, INC. (ZVRA)

Daniel Cohen

A named executive officer of ZEVRA THERAPEUTICS in every fiscal year CompBrief holds from FY2017 to FY2018. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$747,862

Salary $233,333Stock awards $0

FY2017: $748,284

2nd of 5 named executive officers at Zevra Therapeutics by FY2018 total.

5 named officers on file for ZEVRA THERAPEUTICS, FY2018

Daniel Cohen’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how ZEVRA THERAPEUTICS’s whole pay program stands against its peers

  • ZEVRA THERAPEUTICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ZVRA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 15, 2019 (DEF 14A).

Free

Get Daniel Cohen’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Daniel Cohen compensation by year

ZEVRA THERAPEUTICS Summary Compensation Table · all 2 fiscal years held
In US dollars, as ZEVRA THERAPEUTICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018
Salary$350,000$233,333
Bonus$100,000$0
Stock awards$0$0
Option awards$206,419$302,948
Non-equity incentive$66,640$0
Pension and deferred compensation$0$0
All other$25,225$211,581
Total$748,284$747,862

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ZEVRA THERAPEUTICS, INC. DEF 14A filed March 15, 2019, accession 0001193125-19-075693, and prior-year filings. Open the filing on EDGAR.

How this page was built: the ZEVRA THERAPEUTICS, INC. filed document, accession 0001193125-19-075693. Every figure is read from that document and cited to the page and table it appears in. Filed March 15, 2019.

$748K
$748K
FY17
FY18
SalaryBonusNon-equity incentiveOption awardsAll other

ZEVRA THERAPEUTICS’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
Travis MicklePresident and chief executive officer$1,430,639
Daniel Cohen · this pageExecutive vice president, government and public relations$747,862
Sven GuentherExecutive vice president, research and development$693,606
Gordon JohnsonChief business officer$654,166
R. LaDuane CliftonChief financial officer, secretary and treasurer$647,324

The full ZEVRA THERAPEUTICS compensation record

free company brief

This page is one person within ZEVRA THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ZEVRA THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Daniel Cohen's compensation dossier · One-time report. No refunds.